Join us on the latest episode! Our Guest: Pascal Touchon, President and CEO at Atara Biotherapeutics

What you'll get out of this episode:

- Backstory on Pascal
- Leading CAR-T at Novartis and Atara, focusing on lymphoma.
- Creation of EBV T Cell Platform for cancer and autoimmune diseases.
- The milestones for Ebalo, including European approval.
- Impacting cell therapy with validation, quality manufacturing.
- Planned future directions, including FDA alignment and partnerships.

To learn more about Atara Biotherapeutics: https://www.atarabio.com/

Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/
FlipMD by GoodRX https://www.goodrx.com/
Quantum Health https://quantum-health.com/